1. Guillain-Barre study group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome;FGA, Van Der Meche; PIM, Schmitz; the Dutch;N Engl J Med,1992
2. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study;PA, Van Doom; A, Brand; PFW, Strengers; J, Meulstee; M, Vermeulen;Neurology,1990
3. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy;PA, Van Doom; M, Vermeulen; A, Brand; PGH, Mulder; FM, Bisch;Arch Neurol,1991
4. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy; a double-blind, placebo controlled study;Vermeulen, M.; Van Doom, P.A.; Brand, A.; Strengers, P.F.W.; Jennekens, F.G.I.; Busch, H.F.M.;J Neurol Neurosurg Psychiatry,1993
5. Multifocal motor neuropathy: response to human immune globulin;Chaudhry, V.; Corse, A.M.; Comblath, D.R.; Kuncl, R.W.; Drachman, D.B.; Freimer, M.L.; Miller, R.G.; Griffin, J.W.;Ann Neurol,1993